Quent Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.02K Sell
308
-1
-0.3% -$19 ﹤0.01% 1389
2026
Q2
$4.66K Hold
309
– – ﹤0.01% 1371
2026
Q1
$5.92K Sell
309
-148
-32% -$3.22K ﹤0.01% 1247
2025
Q4
$10K Sell
457
-60
-12% -$1.08K ﹤0.01% 1149
2025
Q3
$6.28K Buy
+517
New +$7K ﹤0.01% 1109
2025
Q2
– Sell
-60
Closed -$1.15K – 1147
2025
Q1
$1.15K Hold
60
– – ﹤0.01% 1193
2024
Q4
$2.16K Sell
60
-286
-83% -$9.7K ﹤0.01% 1163
2024
Q3
$14.7K Hold
346
– – ﹤0.01% 941
2024
Q2
$13.9K Hold
346
– – ﹤0.01% 932
2024
Q1
$12.3K Buy
346
+286
+477% +$7.66K ﹤0.01% 976
2023
Q4
$1.78K Sell
60
-34
-36% -$705 ﹤0.01% 1215
2023
Q3
$1.95K Sell
94
-17
-15% -$467 ﹤0.01% 1181
2023
Q2
$2.72K Hold
111
– – ﹤0.01% 1152
2023
Q1
$4.51K Buy
111
+16
+17% +$662 ﹤0.01% 1058
2022
Q4
$4.27K Buy
95
+61
+179% +$2.76K ﹤0.01% 1034
2022
Q3
$2K Hold
34
– – ﹤0.01% 1109
2022
Q2
$2K Hold
34
– – ﹤0.01% 1071
2022
Q1
$4K Hold
34
– – ﹤0.01% 1083
2021
Q4
$5K Buy
+34
New +$4.59K ﹤0.01% 932

Other funds holding TNDM

Quent Capital's TNDM Position: Q3 2026 in Review

Quent Capital reduced its Tandem Diabetes Care (TNDM) stake by 0.32% in Q3 2026, selling an estimated $19 and leaving 308 shares worth $5.02K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

Quent Capital first reported a position in TNDM in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.7K in Q3 2024. 203 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Quent Capital held 308 shares of Tandem Diabetes Care worth $5.02K as of Q3 2026.
  • Quent Capital sold 1 Tandem Diabetes Care share in Q3 2026, an estimated $19.
  • Tandem Diabetes Care made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1389 holding.
  • Quent Capital first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 19 quarters since.
  • Quent Capital's Tandem Diabetes Care position peaked at $14.7K in Q3 2024.
  • 203 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.